126 related articles for article (PubMed ID: 34985580)
21. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of detection of CD99
Zakzok O; Elshanshory M; Zekri W; Elsharkawy N; Zaky I; Salama A; Kamel A; Elantably I; Said S
Pediatr Blood Cancer; 2022 Jan; 69(1):e29298. PubMed ID: 34403190
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability.
Balaraman K; Deniz E; Nelson E; Pilicer SL; Atasoy S; Molotkova A; Sevim H; Tiwari PB; Üren A; Wolf C
Eur J Med Chem; 2023 May; 251():115244. PubMed ID: 36917882
[TBL] [Abstract][Full Text] [Related]
24. Cervical intramedullary recurrent Ewing sarcoma after 10-year disease-free survival in an adult: a case report and review of literature.
Fukushima K; Tsuji O; Suzuki S; Nori S; Nagoshi N; Okada E; Yagi M; Emoto K; Nakayama R; Watanabe K; Nakamura M; Matsumoto M
Spinal Cord Ser Cases; 2021 May; 7(1):45. PubMed ID: 34045432
[TBL] [Abstract][Full Text] [Related]
25. Endometrial endometrioid carcinomas associated with Ewing sarcoma/peripheral primitive neuroectodermal tumor.
Sinkre P; Albores-Saavedra J; Miller DS; Copeland LJ; Hameed A
Int J Gynecol Pathol; 2000 Apr; 19(2):127-32. PubMed ID: 10782408
[TBL] [Abstract][Full Text] [Related]
26. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
[TBL] [Abstract][Full Text] [Related]
27. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.
Chebib I; Jo VY
Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124
[TBL] [Abstract][Full Text] [Related]
28. Ewing Sarcoma and Ewing-Like Sarcoma and the Role of NKX2.2 Immunoreactivity.
Ullah A; Sinkler MA; Velasquez Zarate L; Clavijo A; White J
Cureus; 2021 Aug; 13(8):e17391. PubMed ID: 34584801
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical detection of EWS and FLI-1 proteinss in Ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression.
Llombart-Bosch A; Navarro S
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):255-60. PubMed ID: 11556754
[TBL] [Abstract][Full Text] [Related]
30. Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases.
Machado I; Navarro L; Pellin A; Navarro S; Agaimy A; Tardío JC; Karseladze A; Petrov S; Scotlandi K; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2016 Jun; 22():25-32. PubMed ID: 27180056
[TBL] [Abstract][Full Text] [Related]
31. Adamantinoma-like Ewing Sarcoma of the Nasal Cavity: A Rare Clinical Presentation with Deceptive Histopathologic Features.
Pasricha S; Pahwa S; Jajodia A; Goyal S; Agarwal M; Kumar A; Gupta G; Sharma A; Durga G; Kamboj M; Mehta A
Head Neck Pathol; 2022 Sep; 16(3):865-869. PubMed ID: 34855125
[TBL] [Abstract][Full Text] [Related]
32. CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma.
Czapiewski P; Wełnicka-Jaśkiewicz M; Seroczyńska B; Skokowski J; Sejda A; Szade J; Wiewiora C; Biernat W; Żaczek A
Pol J Pathol; 2015 Sep; 66(3):269-75. PubMed ID: 26619106
[TBL] [Abstract][Full Text] [Related]
33. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
[TBL] [Abstract][Full Text] [Related]
34. Primary pancreatic Ewing sarcoma: a cytomorphologic and histopathologic study of 13 cases.
Miller DL; Roy-Chowdhuri S; Illei P; James A; Hruban RH; Ali SZ
J Am Soc Cytopathol; 2020; 9(6):502-512. PubMed ID: 32536453
[TBL] [Abstract][Full Text] [Related]
35. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
Syed M; Mushtaq S; Loya A; Hassan U
Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
[TBL] [Abstract][Full Text] [Related]
37. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
38. The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma.
Rooper LM; Sharma R; Gocke CD; Belchis DA
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):174-179. PubMed ID: 28800015
[TBL] [Abstract][Full Text] [Related]
39. Ewing sarcoma with myxoid stroma: Case report of an unusual histological variant.
Alexiev BA; Obeidin F; Jennings LJ
Pathol Res Pract; 2019 Dec; 215(12):152665. PubMed ID: 31585812
[TBL] [Abstract][Full Text] [Related]
40. Primary Ewing sarcoma of the kidney: A series of four cases.
Patra S; Trivedi P
Malays J Pathol; 2022 Apr; 44(1):93-99. PubMed ID: 35484891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
